A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010
Clinical trial NCT03311373 · COMPLETED
Trial details
- NCT number
- NCT03311373
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2017-12-15
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.